12.3 Heart Failure, Cardiogenic Shock & Left Ventricular Assist Devices (LVAD)

12.3 Heart Failure, Cardiogenic Shock & Left Ventricular Assist Devices (LVAD)

Pathophysiology of Heart Failure: Forward vs Backward Failure

Heart failure is a complex clinical syndrome resulting from structural or functional cardiac disorders that impair the ventricle's ability to fill with blood (diastolic dysfunction / Heart Failure with preserved Ejection Fraction [HFpEF]) or eject blood forward (systolic dysfunction / Heart Failure with reduced Ejection Fraction [HFrEF]) (CPCF Appendix A #7). Under the Frank-Starling law, physiological stretching of myocardial fibers enhances contractile force; however, in chronic heart failure, excessive ventricular dilation overstretches sarcomeres beyond their optimal overlap, precipitating contractile collapse.

Left-Sided vs Right-Sided Failure

• Left Ventricular Failure: Primary failure of the left ventricle causes backward failure (elevated left ventricular end-diastolic pressure [LVEDP] transmits retrograde into the left atrium and pulmonary venous vasculature, increasing pulmonary capillary hydrostatic pressure) and forward failure (decreased stroke volume and inadequate systemic organ perfusion).
• Right Ventricular Failure: Most commonly caused secondary to chronic left-sided failure (pulmonary venous hypertension transmitting into the pulmonary arterial bed, causing RV hypertrophy and dilatation). Primary causes include acute right ventricular infarction, massive pulmonary embolism, and chronic pulmonary disease (cor pulmonale). Backward failure elevates systemic venous pressures, manifesting as jugular venous distention (JVD), congestive hepatomegaly, hepatojugular reflux, ascites, and dependent peripheral pitting edema.

---

Acute Decompensated Heart Failure (ADHF) & Flash Pulmonary Edema

Acute Decompensated Heart Failure (ADHF) occurs when compensatory neurohormonal mechanisms (sympathetic nervous system activation and the renin-angiotensin-aldosterone system [RAAS]) become maladaptive, triggering severe fluid retention, intense peripheral vasoconstriction, and dramatic afterload elevation.

Hemodynamics of Flash Pulmonary Edema

When pulmonary capillary hydrostatic pressure exceeds plasma oncotic pressure (normally ~25 mmHg), fluid transudation overwhelms lymphatic clearance mechanisms, flooding the pulmonary interstitial space and bursting into the alveoli:

• Severe Dyspnea & Orthopnea: Patients cannot tolerate lying recumbent because venous return from the lower extremities suddenly shifts into the central circulation, overwhelming left ventricular filling capacity.
• Paroxysmal Nocturnal Dyspnea (PND): Awakening gasping for air 1 to 2 hours after retiring, caused by interstitial edema reabsorption while supine.
• Auscultation Findings: Coarse bibasilar crackles (rales) that progress upward to the lung apices as fluid accumulation increases; expiratory wheezes ('cardiac asthma') caused by peribronchial interstitial cuffing compressing small airways; an S3 ventricular gallop (auscultated over the cardiac apex during rapid early ventricular filling of a dilated compliant chamber).
• Pink Frothy Sputum: Microscopic alveolar capillary rupture under extreme hydrostatic pressure extravasates red blood cells and protein-rich fluid into the airways, whipped into a pink foam by respiratory turbulence.

---

Cardiogenic Shock: Hemodynamic Collapse & Clinical Presentation

Cardiogenic shock represents the extreme end-stage manifestation of pump failure, characterized by primary cardiac output failure leading to cellular hypoxia in the presence of adequate intravascular volume.

Diagnostic Hemodynamics

1. Profound Systemic Hypotension: Systolic Blood Pressure (SBP) <90 mmHg or Mean Arterial Pressure (MAP) <65 mmHg, or a >30 mmHg drop from baseline, unresponsive to fluid challenges.
2. Reduced Cardiac Index: Severely depressed cardiac output (cardiac index <2.2 L/min/m²).
3. Elevated Ventricular Filling Pressures: Pulmonary Capillary Wedge Pressure (PCWP) >15 to 18 mmHg (distinguishing cardiogenic shock from hypovolemic and distributive shock).

Physical Exam Triad of Cardiogenic Shock

• Hypoperfusion (Cold Shock): Pale, mottled, cool, and clammy skin; delayed capillary refill (>3 seconds); weak, thready, or non-palpable peripheral pulses.
• Neurocognitive Deterioration: Restlessness, acute confusion, somnolence, and agitation secondary to critically diminished cerebral perfusion.
• End-Organ Failure: Marked oliguria (<0.5 mL/kg/h urine output), progressive lactic acidosis, and severe myocardial ischemia.

[!WARNING] The Vasodilator Trap in Cardiogenic Shock: While vasodilators (nitroglycerin) are first-line agents in hypertensive ADHF with pulmonary edema, they are lethal in cardiogenic shock. Administering nitrates or ACE inhibitors to a hypotensive patient with SBP <90 mmHg abolishes compensatory sympathetic vascular tone, inducing total cardiovascular collapse. Cardiogenic shock requires inotropic and vasopressor support (norepinephrine, dobutamine) per advanced paramedic scope.

---

Prehospital Therapeutics: CPAP Biomechanics & Vasodilator Titration

Prehospital intervention for hypertensive ADHF with severe pulmonary edema focuses on reducing preload, decreasing afterload, and restoring gas exchange:

1. Positioning

Place the patient in an immediate High Fowler's position (sitting completely upright with legs dependent). This mechanically pools blood in the pelvic and lower extremity venous capacitance beds, reducing venous return (preload) to the right heart.

2. Continuous Positive Airway Pressure (CPAP)

CPAP delivered at 5 to 10 cmH2O via an airtight mask is the gold-standard non-invasive respiratory intervention:

• Pulmonary Mechanics: CPAP increases functional residual capacity (FRC), splints open fluid-flooded and collapsed alveoli, and physically drives intra-alveolar transudate back across the alveolar-capillary membrane into interstitial lymphatic beds. Work of breathing is dramatically curtailed.
• Cardiovascular Biomechanics: The elevated positive intrathoracic pressure reduces right ventricular preload (by decreasing the venous return gradient) and reduces left ventricular afterload (by diminishing left ventricular transmural systolic pressure). This double unloading allows the failing myocardium to eject more efficiently.

3. Nitroglycerin Titration

When SBP is >100 to 140 mmHg, sublingual nitroglycerin (0.4 mg spray or tablet every 3 to 5 minutes) acts as an essential pharmacological agent:

• Venodilation (Low Dose): Markedly increases systemic venous capacitance, unloading right ventricular preload and reducing pulmonary capillary hydrostatic pressure.
• Arteriolar Dilation (High Dose): Reduces systemic vascular resistance, decreasing left ventricular afterload and improving forward stroke volume.

---

Continuous-Flow Left Ventricular Assist Devices (LVAD): Engineering & Assessment

A Left Ventricular Assist Device (LVAD) is an implantable mechanical circulatory support pump surgically connected to the heart to manage patients with end-stage heart failure (NYHA Class IV / ACC Stage D) as a 'bridge to transplantation' or 'destination therapy.'

Rotary Continuous-Flow Mechanics

Modern devices (e.g., Abbott HeartMate 3, HeartWare HVAD) utilize continuous-flow centrifugal or axial rotary impellers suspended by magnetic levitation. Blood is drawn directly from the apex of the left ventricle via an inflow cannula and propelled continuously through an outflow cannula into the ascending aorta. Because the impeller operates continuously at thousands of revolutions per minute (e.g., 5,000–9,000 RPM):

• Non-Pulsatile Circulation: There is no distinct cardiac systole or diastole generated by the pump. The arterial circulation is continuous and laminar.
• Absence of Palpable Pulse: In up to 70% to 80% of LVAD patients, peripheral pulses are completely non-palpable (even though the patient is fully conscious, warm, and talking).
• Automated BP Monitors Fail: Standard automated oscillometric NIBP cuffs rely on arterial wall pulse oscillations; they repeatedly display error codes or fail to detect a blood pressure in continuous-flow LVAD patients.
• Pulse Oximetry Inefficacy: Standard pulse oximeters require pulsatile capillary beds; they frequently fail to track or display an SpO2 waveform.

The External Hardware Components

1. Percutaneous Driveline: A specialized cable emerging from the patient's upper abdomen, connecting the internal pump to the external controller.
2. System Controller: A wearable microprocessor unit that monitors pump speed, electrical power, flow rate, and diagnostic alarms.
3. Power Sources: Two lithium-ion batteries or an external AC wall power unit connected to the controller via heavy-duty cables.

---

Hemodynamic Monitoring in LVAD: Doppler Mean Arterial Pressure (MAP)

Because arterial flow is non-pulsatile, clinicians cannot obtain standard systolic and diastolic blood pressure readings. Hemodynamic perfusion in an LVAD patient is assessed exclusively via the Mean Arterial Pressure (MAP) using a manual sphygmomanometer and Doppler ultrasound probe:

1. Place a manual adult blood pressure cuff on the patient's upper arm.
2. Apply ultrasound transmission gel over the brachial or radial artery and position an 8-MHz vascular Doppler probe at a 45-degree angle to the vessel until a distinct continuous, whooshing arterial flow signal is heard.
3. Inflate the manual cuff until the Doppler flow sound completely disappears.
4. Slowly deflate the cuff at 2 mmHg per second. The precise manometer reading at which the continuous Doppler flow sound first reappears represents the patient's Mean Arterial Pressure (MAP).

Target MAP Range & Clinical Significance

• Target MAP: 70 to 90 mmHg.
• Hypertension (MAP >90–95 mmHg): Dramatically elevates LVAD afterload. Excessive afterload slows pump flow, increases turbulent shear stress on blood cells, triggers hemolysis, and substantially increases the risk of hemorrhagic stroke and pump thrombosis.
• Hypotension (MAP <65 mmHg): Reflects hypovolemia, sepsis, occult gastrointestinal bleeding (common in LVADs due to acquired von Willebrand syndrome and arteriovenous malformations), or acute right ventricular failure.

---

LVAD Troubleshooting, Alarms & Cardiac Arrest Resuscitation

When assessing an unstable LVAD patient, paramedics must follow a systematic evaluation pathway:

LVAD Emergency Assessment Pathway:
1. Check Consciousness & Perfusion (Warm/pink? Alert?)
2. Auscultate Precordium / Epigastrium (Is the continuous pump 'hum' present?)
3. Inspect System Controller Display (Alarms? Speed? Flow? Power? PI?)
4. Check Driveline (Intact? Disconnected? Trauma?)
5. Check Power Supply (Secure battery cables? Backup batteries available?)
6. Obtain Doppler MAP (Target 70–90 mmHg)
7. Contact Regional VAD Coordinator (Phone number on controller tag)

Controller Alarms & Troubleshooting

• Beeping Alarm / Flashing Yellow: Advisory alarm (e.g., low battery ~15 minutes remaining). Immediately switch to fully charged backup batteries one at a time.
• Continuous Siren / Flashing Red: Critical alarm (e.g., pump stopped, driveline disconnected, critical system fault). Check connections immediately. Firmly reconnect any loose driveline or power cables.

Cardiac Arrest & Resuscitation in LVAD Patients

If an LVAD patient is found unresponsive, apneic, and non-perfusing (Doppler MAP <50 mmHg or ETCO2 <20 mmHg with alarms):

1. Auscultate for Pump Hum: If no mechanical hum is heard, immediately inspect the driveline and power connections. Often, re-establishing power or securing a loose plug restarts the pump and restores instant perfusion.
2. Manual Chest Compressions (The Current Consensus): Historically, chest compressions were discouraged due to theoretical risks of dislodging the LVAD inflow cannula. Current international guidelines (AHA and International Society for Heart and Lung Transplantation [ISHLT]) endorse performing standard manual chest compressions if the patient is unresponsive, apneic, and confirmed non-perfusing. The risk of death from untreated circulatory arrest far exceeds the low mechanical risk of cannular disruption.
3. Electrical Defibrillation & Cardioversion: Completely safe and indicated for shockable rhythms (VF/pVT). Defibrillation does not damage the internal pump rotor. Defibrillation pads must be placed in standard anterior-lateral or anterior-posterior positions, ensuring pads are at least 5 cm (2 inches) away from the internal pump housing and external controller.

---

Clinical Scenario: Severe ADHF with Flash Pulmonary Edema

A 74-year-old male with a history of anterior myocardial infarction and chronic systolic heart failure presents with sudden severe respiratory distress. The paramedic crew finds him sitting bolt upright at the kitchen table, gasping, diaphoresis drenching his shirt, unable to speak in full sentences, and coughing up pink, frothy sputum.

1. Primary Assessment: Severe respiratory fatigue, RR 36/min with intercostal retractions, SpO2 76% on ambient air. Auscultation reveals diffuse bubbling crackles bilaterally to the apices and an S3 gallop. Vital signs: BP 196/110 mmHg, HR 122 bpm irregular (atrial fibrillation), clear JVD.
2. Immediate Positioning & High-Flow Oxygen: The patient is kept strictly upright. High-flow oxygen is provided while setting up the non-invasive ventilation circuit.
3. CPAP Initiation: CPAP mask applied with PEEP set at 5 cmH2O and titrated to 7.5 cmH2O. Inspired oxygen concentration is adjusted to maintain SpO2 >92%.
4. Vasodilator Administration: Confirming SBP is well above the 100 mmHg threshold (196 mmHg), the paramedic administers sublingual nitroglycerin 0.4 mg spray. Over the next 15 minutes, two additional 0.4 mg doses are delivered at 5-minute intervals under continuous BP monitoring.
5. Response to Therapy: Within 10 minutes, the combination of CPAP alveolar recruitment and nitroglycerin preload/afterload reduction breaks the hydrostatic pulmonary crisis. The patient's respiratory rate settles to 22/min, crackles recede to the lung bases, pink sputum ceases, SpO2 rises to 94%, and BP moderates to 148/88 mmHg.

---

Exam Pitfalls & High-Yield LVAD Pearls

• Assuming Cardiac Arrest Due to Lack of Palpable Pulse: Never start CPR on an alert, speaking LVAD patient simply because you cannot feel a radial or carotid pulse. Pulselessness is expected in continuous-flow devices.
• Using Automated BP Cuffs on LVAD Patients: Wasting precious scene time trying to obtain an automated NIBP reading is an exam failure; immediately reach for the Doppler probe and manual sphygmomanometer to obtain the MAP.
• Ignoring Preload in LVAD Hypotension: An LVAD cannot pump blood that does not reach it. If the right ventricle fails or the patient is severely dehydrated, the LVAD will experience a 'suction event' (inflow cannula collapses against the ventricular septum). Treatment for low LVAD flow with hypotension is gentle IV fluid boluses, not vasopressors.
• Delaying Contact with the VAD Coordinator: Every LVAD patient carries an emergency contact card with the 24/7 direct phone line to their hospital VAD coordinator. Paramedics should contact this specialist early for real-time troubleshooting.